<p>Survivors (65) included participants who completed the study (32), participants who died before completion of the study (3) and excluded patients (9). Non-participants (21) included missed patients (15) and those who declined to participate (6).</p
<p>This trial enrolled 56 participants, in which seven patients were excluded as they did not meet i...
* 8 were excluded in the FMS-group: 1 Ehlers-Danlos syndrome, 1 unclear autoimmune disease, 1 stroke...
<p>Study participants were split into two groups, those who returned to the convalescent visit (left...
<p>Age, gender, and clinical variables for survivors of ECLS discharged from hospital, and participa...
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
<p>In total, 61 patients were enrolled and entered into the final analysis of the study.</p
<p>The number of patients and visits at each year of the study are reported into brackets. Five pati...
The flowchart shows the number of volunteers participating in the inceptive examination and the 3-ye...
<p>Flow chart of the patients included into the late post-conditioning study and patients that could...
121 participants were assessed for eligibility and included in the study. 3 participants were exclud...
<p>Of the 250 patients who were enrolled, 209 patients (azelnidipine group: 103 patients, trichlorme...
Study flow chart, showing how the COVID-19 survivors were selected to participate in this follow-up ...
<p>Fig 1 shows the flow diagram of participants in this study. We began with records of all patients...
<p>Of 151 patients underwent screening, 151 met eligibility criteria and 142 were included for analy...
108 patients were assessed for eligibility. Ten patients did not fulfil the study criteria and ten d...
<p>This trial enrolled 56 participants, in which seven patients were excluded as they did not meet i...
* 8 were excluded in the FMS-group: 1 Ehlers-Danlos syndrome, 1 unclear autoimmune disease, 1 stroke...
<p>Study participants were split into two groups, those who returned to the convalescent visit (left...
<p>Age, gender, and clinical variables for survivors of ECLS discharged from hospital, and participa...
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
<p>In total, 61 patients were enrolled and entered into the final analysis of the study.</p
<p>The number of patients and visits at each year of the study are reported into brackets. Five pati...
The flowchart shows the number of volunteers participating in the inceptive examination and the 3-ye...
<p>Flow chart of the patients included into the late post-conditioning study and patients that could...
121 participants were assessed for eligibility and included in the study. 3 participants were exclud...
<p>Of the 250 patients who were enrolled, 209 patients (azelnidipine group: 103 patients, trichlorme...
Study flow chart, showing how the COVID-19 survivors were selected to participate in this follow-up ...
<p>Fig 1 shows the flow diagram of participants in this study. We began with records of all patients...
<p>Of 151 patients underwent screening, 151 met eligibility criteria and 142 were included for analy...
108 patients were assessed for eligibility. Ten patients did not fulfil the study criteria and ten d...
<p>This trial enrolled 56 participants, in which seven patients were excluded as they did not meet i...
* 8 were excluded in the FMS-group: 1 Ehlers-Danlos syndrome, 1 unclear autoimmune disease, 1 stroke...
<p>Study participants were split into two groups, those who returned to the convalescent visit (left...
DOI
Add to ORKG